ARTICLE | Politics, Policy & Law
Stem cell workaround in EU
Working around Europe's human embryonic stem cells patent decision
October 31, 2011 7:00 AM UTC
The sky isn't falling for embryonic stem cell technologies in Europe. Despite a broad ruling by the European Court of Justice that products derived from embryonic stem cells cannot be patented, the scientific complexity of turning such cells into products should provide a high barrier to competition.
Additionally, new techniques that avoid embryo destruction, along with iPS and adult-derived stem cell sources, are not affected by the ruling and provide patentable avenues for developing stem cell-based therapies...